We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · April 14, 2021

Modified Immune Prognostic Index to Prognosticate Outcomes in ICI-Treated Metastatic Uveal Melanoma

Cancer Medicine


Additional Info

Cancer Medicine
Evaluation of the Modified Immune Prognostic Index to Prognosticate Outcomes in Metastatic Uveal Melanoma Patients Treated With Immune Checkpoint Inhibitors
Cancer Med 2021 Mar 16;[EPub Ahead of Print], MS Sander, I Stukalin, IA Vallerand, S Goutam, BW Ewanchuk, DE Meyers, A Pabani, DG Morris, DYC Heng, T Cheng

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading